Earn FREEAMA PRA Category 1 Credit™ for Searching Medical Articles

FACULTY DISCLOSURE: In accordance with the Accreditation Council for Continuing Medical Education's Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the Activity Directors, planning committee members, planners, authors and staff involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. It is the policy of Hospital for Special Surgery to request all financial relationships that Activity Directors, planning committee members, planners, authors and staff have with commercial interests, but to disclose to the activity audience only the relevant financial relationships. The following Activity Directors/Planning Committee Members have disclosed no relevant financial relationships: Activity Director/Planning Committee Member: Greg Chang, MHA; Planning Committee Members: Tonie Costello, LCSW; Amy R. DeRobertis, MS, Sameer Tanakia

May 3rd, 2010//Vol. 159 Iss. 5//pgs. 803-808.e1

Background

Although pathomechanisms of avascular necrosis (AVN) of the femoral head are not well-known, vascular and coagulation abnormalities have been proposed as hypotheses. We propose that the pathomechanisms of AVN could also involve the cardiovascular system. This study explores the risk of coronary heart disease (CHD) after AVN, through a population-based case-control approach.

Methods

We identified 1,450 patients with AVN as the study group and randomly selected 7,250 patients as the comparison group. Each patient was individually tracked for 3 years to identify all who developed CHD during the follow-up period. Cox proportional hazards regressions were performed to calculate the hazard ratios (HRs) of CHD for the 2 groups.

Results

In total, 90 patients (6.21%) from the study group and 295 patients (4.07%) from the comparison group developed CHD during the follow-up period. Compared with patients in the comparison group, the HR for CHD among patients with AVN was 1.43 (95% CI 1.10-1.86, P = .002), after adjusting for geographic variables and cardiovascular risk factors. Among males, the adjusted HR for CHD was 1.65 (95% CI 1.20-2.27, P < .001). For patients <65 years old with AVN, the adjusted HR for CHD was 1.42 (95% CI 1.02-1.98, P = .021). There was no significant difference in the HR for CHD among females with AVN and patients > or =65 years old.

Conclusion

The incidence of CHD in the 3 years after AVN is significantly higher than in the general population.

Please give us your feedback by completing the above evaluation. All fields are required. The Accreditation Council for Continuing Medical Education requires that accredited CME providers evaluate and assess the effectiveness of all Continuing Medical Education accredited activities. This evaluation will help us document our efforts to address physician’s practice gaps and educational needs.